Participation, barriers, and facilitators of cancer screening among LGBTQ+ populations: A review of the literature

Prev Med. 2023 May:170:107478. doi: 10.1016/j.ypmed.2023.107478. Epub 2023 Mar 13.

Abstract

The LGBTQ+ community is at higher risk of certain cancers but is less likely to participate in screening programs or engage with preventive healthcare. Despite this, the barriers and facilitators to cancer screening are not well understood in this population. We conducted a literature review of research related to LGBTQ+ participation in cancer screening, as well as barriers and facilitators to participation. Following abstract and full-text screening, 50 studies were included in the final synthesis. Compared to their heterosexual counterparts, lesbian and bisexual women were less likely to participate in cervical cancer screening and mammography, but gay and bisexual men were more likely to participate in anal and colorectal cancer screening. Transgender individuals had lower rates of screening than cisgender individuals for all cancer types. Barriers to participation were found at the individual-, provider-, and administrator-level, and good communication with a healthcare provider was the strongest facilitator. These results provide reasonable first steps toward improving participation rates for LGBTQ+ populations in cancer screening. Patient-centered approaches should draw on core guiding principles to inform the provision of care, including anticipating LGBTQ+ patients, improving knowledge about care for these patients, and confronting individually-held biases that may affect care, in order to improve care experiences and participation rates in preventive services.

Keywords: Cancer screening; Equity; Lgbtq; Sexual and gender minorities.

Publication types

  • Review

MeSH terms

  • Early Detection of Cancer
  • Female
  • Homosexuality, Female*
  • Humans
  • Male
  • Sexual Behavior
  • Sexual and Gender Minorities*
  • Transgender Persons*
  • Uterine Cervical Neoplasms* / diagnosis
  • Uterine Cervical Neoplasms* / prevention & control